Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma

This cohort study assesses the risk of breakthrough SARS-CoV-2 infection and hospitalization among fully vaccinated patients with multiple myeloma.

Detalles Bibliográficos
Autores principales: Wang, Lindsey, Berger, Nathan A., Xu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611483/
https://www.ncbi.nlm.nih.gov/pubmed/34812850
http://dx.doi.org/10.1001/jamanetworkopen.2021.37575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611483/
https://www.ncbi.nlm.nih.gov/pubmed/34812850
http://dx.doi.org/10.1001/jamanetworkopen.2021.37575

Ejemplares similares